Multiple Myeloma an incurable disease, but I have spent the last 25 years in remission using a blend of conventional oncology and evidence-based nutrition, supplementation, and lifestyle therapies from peer-reviewed studies that your oncologist probably hasn't told you about.
Click the orange button to the right to learn more about what you can start doing today.
My grandmother and mother both lost their lives to Multiple Myeloma. My mom passed on 2/2019 just 3 months after her MM diagnosis.
She never had any pain at all. Its a long and complicated explanation. To make a long story short. She started her MM treatment and a week later was hospitalized with heart failure. She was gone a month later.
Five months later I started having shortness of breath, rib pain, fatigue. I just had kidney stones and my kidney function is normal. I am pretty anemic as well. Also I need to drop about 60lbs. I haven’t seen a doctor yet. Im terrified. What do you recommend? Thank you! Lenora
I don’t see any real specific information that you can act on. It is not as if we are talking about breast cancer and you have either the BRCA 1 or 2 gene.
What do I recommend?
Go see an oncologist. Ask him/her to run
diagnostic testing that he/she would use to identify multiple myeloma. Again, even if you are diagnosed with MM, the sooner you find out, the better.
Regardless of what, if anything the oncologist finds out, I encourage you to undergo a non-toxic, anti-MM lifestyle through
Frequent, moderate exercise, more fruits and veggies, less sugar, less animal fat, etc. are all steps you can undergo that will decrease your risk to MM certainly, but will also decrease your risks to a host of other chronic diseases.
Let me know if you have any other questions. Let me know wha the oncologist says.
“Family pedigree analyses of high-risk families, case-control studies and racial disparities in disease incidence all point to a potential inherited predisposition to MM…
Genome-wide association studies (GWASs) have identified susceptibility loci in a number of cancers and such studies are currently underway in MM. To date, GWASs in MM have identified several potential regions of interest for further study on chromosomes 3p22, 7p15.3, 8q24 and 2p23.3.
In addition, several targets of paraproteins (so called ‘paratargs’) in MM have been identified. Hyperphosphorylation of the paratarg protein, which is inherited in an autosomal dominant manner, appears a common mechanism underlying the antigenicity of these proteins.
One particular protein, hyperphosphorylated paratarg-7 (pP-7) is a common target in persons with myeloma and has also been identified in affected members of several high-risk MM families…
“Multiple myeloma (MM) is the second most common blood malignancy. Epidemiological family studies going back to the 1920s have provided evidence for familial aggregation, suggesting a subset of cases have an inherited genetic background.
Recently, studies aimed at explaining this phenomenon have begun to provide direct evidence for genetic predisposition to MM. Genome-wide association studies have identified common risk alleles at 24 independent loci.
Sequencing studies of familial cases and kindreds have begun to identify promising candidate genes where variants with strong effects on MM risk might reside. Finally, functional studies are starting to give insight into how identified risk alleles promote the development of MM. Here, we review recent findings in MM predisposition field, and highlight open questions and future directions.”